TEST BANK FOR Advanced Practice Nursing
vn vn vn vn vn
in the Care of Older Adults, 3rd Edition
vn vn vn vn vn vn vn vn vn
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
vn vn vn vn vn vn vn vn
,Answers at the end of the Chapter
vn vn vn vn vn vn vn
Chapter 1: Changes with Aging vn vn vn vn
Multiple Choice vn
Identify the choice that best completes the statement or answers the question.
vn vn vn vn vn vn vn vn vn vn vn
1. The major impact of the physiological changes that occur with aging is:
vn vn vn vn vn vn vn vn vn vn vn
A. Reduced physiological reserve
vn vn
B. Reduced homeostatic mechanisms
vn vn
C. Impaired immunological response
vn vn
D. All of the above
vn vn vn
2. The strongest evidence regarding normal physiological aging is available through:
vn vn vn vn vn vn vn vn vn
,A. Randomized controlled clinical trials vn vn vn
B. Cross-sectional studies vn
C. Longitudinal studies vn
D. Case control studies
vn vn
3. All of the following statements are true about laboratory
vn vn v n v n vn vn vn vn vn vn vn vn
values in older adultsexcept:
vn vn vn
A. Reference ranges are preferable
vn vn vn
B. Abnormal findings are often due to physiological aging
vn vn vn vn vn vn vn
C. Normal ranges may not be applicable for older adults
vn vn vn vn vn vn vn vn
D. Reference values are not necessarily acceptable values
vn vn vn vn vn vn
vn vn v n 4. v n Biochemical individuality is best described as:
vn vn vn vn vn
A. Each individual’s variation is often much greater than that of a larger group
vn vn vn vn vn vn vn vn vn vn vn vn
B. The unique biochemical profile of a selected population
vn vn vn vn vn vn vn
C. The truly “normal” individual—falling within average range
vn vn vn vn vn vn
D. Each individual’s variation is often much smaller than that of a larger group
vn vn vn vn vn vn vn vn vn vn vn vn
vn vn v n 5. v n Polypharmacy is best described as taking: vn vn vn vn vn
A. More than nine medications per day
vn vn vn vn vn
B. More than five medications per day
vn vn vn vn vn
, C. Even a single medication if there is not a clear indication for its use
vn vn vn vn vn vn vn vn vn vn vn vn vn
D. When a drug is given to treat the side effect of another drug
vn vn vn vn vn vn vn vn vn vn vn vn
vn vn v n 6. v n Pharmacokinetic changes with aging is reflective of: vn vn vn vn vn vn
A. What the drug does to the body
vn vn vn vn vn vn
B. What the body does to the drug
vn vn vn vn vn vn
C. The effect at the site of action and the time and intensity of the drug
vn vn vn vn vn vn vn vn vn vn vn vn vn vn
D. The side effects commonly associated with the drug
vn vn vn vn vn vn vn
vn vn v n 7. All the following statements are false about drug absorption except:
v n vn vn vn vn vn vn vn vn vn
A. Antacids increase the bioavailability of digitalis
vn vn vn vn vn
B. Gastric acidity decreases with age
vn vn vn vn
C. Anticholinergics increase colonic motility vn vn vn
D. Underlying chronic disease has little impact on drug absorption
vn vn vn vn vn vn vn vn
8. All of the following statements are true about drug distribution in the
vn vn v n v n vn vn vn vn vn vn vn vn vn vn vn
elderly except: vn
A. Drugs distributed in water have lower concentration
vn vn vn vn vn vn
B. Drugs distributed in fat have less intense, more prolonged effect
vn vn vn vn vn vn vn vn vn
C. Drugs highly protein bound have greater potential to cause an adverse drug reaction
vn vn vn vn vn vn vn vn vn vn vn vn
vn vn vn vn vn
in the Care of Older Adults, 3rd Edition
vn vn vn vn vn vn vn vn vn
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
vn vn vn vn vn vn vn vn
,Answers at the end of the Chapter
vn vn vn vn vn vn vn
Chapter 1: Changes with Aging vn vn vn vn
Multiple Choice vn
Identify the choice that best completes the statement or answers the question.
vn vn vn vn vn vn vn vn vn vn vn
1. The major impact of the physiological changes that occur with aging is:
vn vn vn vn vn vn vn vn vn vn vn
A. Reduced physiological reserve
vn vn
B. Reduced homeostatic mechanisms
vn vn
C. Impaired immunological response
vn vn
D. All of the above
vn vn vn
2. The strongest evidence regarding normal physiological aging is available through:
vn vn vn vn vn vn vn vn vn
,A. Randomized controlled clinical trials vn vn vn
B. Cross-sectional studies vn
C. Longitudinal studies vn
D. Case control studies
vn vn
3. All of the following statements are true about laboratory
vn vn v n v n vn vn vn vn vn vn vn vn
values in older adultsexcept:
vn vn vn
A. Reference ranges are preferable
vn vn vn
B. Abnormal findings are often due to physiological aging
vn vn vn vn vn vn vn
C. Normal ranges may not be applicable for older adults
vn vn vn vn vn vn vn vn
D. Reference values are not necessarily acceptable values
vn vn vn vn vn vn
vn vn v n 4. v n Biochemical individuality is best described as:
vn vn vn vn vn
A. Each individual’s variation is often much greater than that of a larger group
vn vn vn vn vn vn vn vn vn vn vn vn
B. The unique biochemical profile of a selected population
vn vn vn vn vn vn vn
C. The truly “normal” individual—falling within average range
vn vn vn vn vn vn
D. Each individual’s variation is often much smaller than that of a larger group
vn vn vn vn vn vn vn vn vn vn vn vn
vn vn v n 5. v n Polypharmacy is best described as taking: vn vn vn vn vn
A. More than nine medications per day
vn vn vn vn vn
B. More than five medications per day
vn vn vn vn vn
, C. Even a single medication if there is not a clear indication for its use
vn vn vn vn vn vn vn vn vn vn vn vn vn
D. When a drug is given to treat the side effect of another drug
vn vn vn vn vn vn vn vn vn vn vn vn
vn vn v n 6. v n Pharmacokinetic changes with aging is reflective of: vn vn vn vn vn vn
A. What the drug does to the body
vn vn vn vn vn vn
B. What the body does to the drug
vn vn vn vn vn vn
C. The effect at the site of action and the time and intensity of the drug
vn vn vn vn vn vn vn vn vn vn vn vn vn vn
D. The side effects commonly associated with the drug
vn vn vn vn vn vn vn
vn vn v n 7. All the following statements are false about drug absorption except:
v n vn vn vn vn vn vn vn vn vn
A. Antacids increase the bioavailability of digitalis
vn vn vn vn vn
B. Gastric acidity decreases with age
vn vn vn vn
C. Anticholinergics increase colonic motility vn vn vn
D. Underlying chronic disease has little impact on drug absorption
vn vn vn vn vn vn vn vn
8. All of the following statements are true about drug distribution in the
vn vn v n v n vn vn vn vn vn vn vn vn vn vn vn
elderly except: vn
A. Drugs distributed in water have lower concentration
vn vn vn vn vn vn
B. Drugs distributed in fat have less intense, more prolonged effect
vn vn vn vn vn vn vn vn vn
C. Drugs highly protein bound have greater potential to cause an adverse drug reaction
vn vn vn vn vn vn vn vn vn vn vn vn
